Centers for Disease Control (CDC)
The questions in this section are laboratory-specific and should be directed to the facility’s laboratory director or other staff that have knowledge of the
practices at the laboratory that performs the facility’s C. difficile testing.
Centers for Disease Control (CDC)
This assessment is meant to capture your awareness and perceptions of policies and practices related to CDI prevention at the facility or unit in which
this assessment is being administered.
Centers for Disease Control (CDC)
The National Action Plan directs federal agencies to accelerate response to antibiotic resistance by presenting coordinated, strategic actions to improve the health and well-being of all Americans across the One Health spectrum. It has pushed transformative improvements across the country that strengthen and expand the ability to respond to these threats. The National Action Plan supports five main goals: 1. Slow the Emergence of Resistant Bacteria and Prevent the Spread of Resistant Infections; 2. Strengthen National One Health Surveillance Efforts to Combat Resistance; 3. Advance Development and Use of Rapid and Innovative Diagnostic Tests for Identification and Characterization of Resistant Bacteria; 4. Accelerate Basic and Applied Research and Development for New Antibiotics, Other Therapeutics, and Vaccines; and 5. Improve International Collaboration and Capacities for Antibiotic-Resistance Prevention, Surveillance, Control and Antibiotic Research and Development.
Agency for Healthcare Research and Quality (AHRQ)
This resource reviews approaches to the diagnosis of sepsis, describes approaches to empiric treatment of sepsis, supports the recognition of when to stop and narrow antibiotic therapy in patients with suspected sepsis and discusses durations of therapy for patients with sepsis.
Centers for Disease Control (CDC)
Provides examples resources on implementing the CDC Targeted Assessment for Prevention (TAP) strategy to prevent CLABSI.
Centers for Disease Control (CDC), NHSN
National Healthcare Safety Network (NHSN, CDC) CLABSI definitions, criteria and surveillance.
Centers for Disease Control (CDC)
These guidelines have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings. The guidelines provide a summary of recommendations to prevent Intravascular Catheter-Related Infections.
Agency for Healthcare Research and Quality (AHRQ)
The Toolkit for Reducing Central Line-Associated Blood Stream Infections (CLABSI) can help your unit implement evidence-based practices to reduce and, in many cases, eliminate CLABSI. More than 1,000 intensive care units across the country reduced CLABSI rates by 41 percent when their clinical teams used the tools in this toolkit along with the Core CUSP Toolkit. The Core CUSP Toolkit provides training materials and resources to help clinical teams learn a method that can help them make care safer by combining improved teamwork, clinical best practices, and the science of safety.
Centers for Disease Control (CDC)
This document is intended for use by infection prevention staff, healthcare epidemiologists, healthcare administrators, nurses, other healthcare providers, and persons responsible for developing, implementing, and evaluating infection prevention and control programs for healthcare settings across the continuum of care. The guideline can also be used as a resource for societies or organizations that wish to develop more detailed implementation guidance for
prevention of CAUTI.
Centers for Disease Control (CDC)
Provides examples resources on implementing the CDC Targeted Assessment for Prevention (TAP) strategy to prevent CAUTI.
Agency for Healthcare Research and Quality (AHRQ)
The Toolkit for Reducing Catheter-Associated Urinary Tract Infections (CAUTI) in Hospitals helps hospitals prevent CAUTI in patients and improve safety culture at the unit level by implementing concepts from the Comprehensive Unit-based Safety Program (CUSP). Health care professionals can use it to make care safer by following clinical best practices and creating a culture of safety. The toolkit has evidence-based, practical resources that reflect the real-world experiences of the frontline providers and researchers who participated in a national implementation project to reduce CAUTIs. It builds on the core CUSP toolkit by providing specific tools focused on reducing CAUTI in hospitals.
Agency for Healthcare Research and Quality (AHRQ)
This tool is an example of a clinical pathway, detailing the relationship among the different components of pressure ulcer prevention. This tool can be used by the hospital unit team in designing a new system, as a training tool for frontline staff, and as an ongoing clinical reference tool on the units. This tool can be modified or a new one created to meet the needs of your particular setting. If you prepared a process map describing your current practices, you can compare that to desired practices outlined on the clinical pathway.
